Ribosomal proteins: a novel class of oncogenic drivers

Oncotarget. 2017 Sep 11;8(52):89427-89428. doi: 10.18632/oncotarget.20802. eCollection 2017 Oct 27.

Authors

Sergey O Sulima¹, Kim De Keersmaecker¹

Affiliation

¹ Department of Oncology, KU Leuven, University of Leuven, Leuven Cancer Institute, Leuven, Belgium.

No abstract available

Keywords: RPL5; bortezomib; proteasome inhibitor; ribosome; ribosomopathies.

Publication types

Editorial